Search research articles
Contact Us
Filters
Showing results (21-30 of 51) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2013
De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial
Paul A Fields, William Townsend, Andrew Webb, et al.
Blood Advances
|
September 3, 2021
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
Alex F Herrera, Catherine Burton, John Radford, et al.
Nature Communications
|
October 25, 2022
Common evolutionary origin of acoustic communication in choanate vertebrates
Gabriel Jorgewich-Cohen, Simon William Townsend, Linilson Rodrigues Padovese, et al.
JU Open Plus
|
January 8, 2024
Technical surgical skill assessment of neurovascular bundle dissection and urinary continence recovery after robotic-assisted radical prostatectomy
Runzhuo Ma, Steven Cen, Edward Forsyth, et al.
British Journal of Haematology
|
November 12, 2019
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)
William Townsend, Sarah Leong, Peter Hoskin, et al.
Leukemia
|
February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.
European Journal of Haematology
|
November 7, 2020
Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real-World Experience from 554 sequential core biopsies from a single centre
Oliver C Cohen, Maximillian H Brodermann, Aoife Dervin, et al.
Therapeutic Advances in Hematology
|
June 5, 2023
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia
Wojciech Jurczak, Nagah Elmusharaf, Christopher P Fox, et al.
British Journal of Haematology
|
February 22, 2022
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline
George A Follows, Sally F Barrington, Kaljit S Bhuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2019
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study
Sally F Barrington, Elizabeth H Phillips, Nicholas Counsell, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 51) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 14, 2013
De novo treatment of diffuse large B-cell lymphoma with rituximab, cyclophosphamide, vincristine, gemcitabine, and prednisolone in patients with cardiac comorbidity: a United Kingdom National Cancer Research Institute trial
Paul A Fields, William Townsend, Andrew Webb, et al.
Blood Advances
|
September 3, 2021
Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial
Alex F Herrera, Catherine Burton, John Radford, et al.
Nature Communications
|
October 25, 2022
Common evolutionary origin of acoustic communication in choanate vertebrates
Gabriel Jorgewich-Cohen, Simon William Townsend, Linilson Rodrigues Padovese, et al.
JU Open Plus
|
January 8, 2024
Technical surgical skill assessment of neurovascular bundle dissection and urinary continence recovery after robotic-assisted radical prostatectomy
Runzhuo Ma, Steven Cen, Edward Forsyth, et al.
British Journal of Haematology
|
November 12, 2019
Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012)
William Townsend, Sarah Leong, Peter Hoskin, et al.
Leukemia
|
February 27, 2024
Long-term outcomes by bone marrow B-cell depletion from the R2W trial of bortezomib with cyclophosphamide and rituximab in Waldenstrőm macroglobulinaemia
Ruth de Tute, Nicholas Counsell, Laura Clifton-Hadley, et al.
European Journal of Haematology
|
November 7, 2020
Lymph node core biopsies reliably permit diagnosis of lymphoproliferative diseases. Real-World Experience from 554 sequential core biopsies from a single centre
Oliver C Cohen, Maximillian H Brodermann, Aoife Dervin, et al.
Therapeutic Advances in Hematology
|
June 5, 2023
Phase I/II results of ceralasertib as monotherapy or in combination with acalabrutinib in high-risk relapsed/refractory chronic lymphocytic leukemia
Wojciech Jurczak, Nagah Elmusharaf, Christopher P Fox, et al.
British Journal of Haematology
|
February 22, 2022
Guideline for the first-line management of Classical Hodgkin Lymphoma - A British Society for Haematology guideline
George A Follows, Sally F Barrington, Kaljit S Bhuller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 22, 2019
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study
Sally F Barrington, Elizabeth H Phillips, Nicholas Counsell, et al.
Page
of 6